Concordance Between ctDNA Assay and FoundationOne

CompletedOBSERVATIONAL
Enrollment

1,400

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Circulating Tumor DNACancerNeoplasmsGenomic TestingGenomic Alterations
Trial Locations (1)

02141

Foundation Medicine, Cambridge

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

Oncology Consultants

UNKNOWN

collaborator

Comprehensive Blood and Cancer Center

OTHER

collaborator

Illinois CancerCare

OTHER

collaborator

Sanford Health

OTHER

collaborator

Eastchester Center for Cancer Care

OTHER

collaborator

Rutgers Cancer Institute of New Jersey

OTHER

collaborator

Cone Health

OTHER

collaborator

Nebraska Cancer Specialists

UNKNOWN

collaborator

University of California, Davis

OTHER

collaborator

University of Chicago

OTHER

collaborator

Northeast Georgia Medical Center

UNKNOWN

collaborator

Hematology Oncology Associates of Fredericksburg

UNKNOWN

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

Oncology Hematology Care, Inc

UNKNOWN

collaborator

Montefiore Medical Center

OTHER

collaborator

Quincy Medical Group

OTHER

collaborator

Prisma Health-Upstate

OTHER

collaborator

Mary Crowley Cancer Research Center

UNKNOWN

collaborator

Texas Health

UNKNOWN

collaborator

University of California, San Diego

OTHER

collaborator

Avera Cancer Institute

UNKNOWN

lead

Foundation Medicine

INDUSTRY